Back to search

Article

A three lncRNA set: AC009975.1, POTEH-AS1 and AL390243.1 as nodal efficacy biomarker of neoadjuvant therapy for HER-2 positive breast cancer

2021-09-21

Abstract excerpt

<title>Abstract</title> <p>Background and purpose LncRNAs have been found to play regulatory role in the chemoresistance after neoadjuvant therapy (NAT) of breast cancers. The breast pathological complete response (pCR) was different from the axillary nodal pCR (apCR) after NAT. And this difference was most significant in HER-2 positive (HER2+) subtype. The aim was to explore whether lncRNA expression in primary...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
da7fff42-a2f2-5195-9ba3-2997761c3c45
DOI
10.21203/rs.3.rs-892533/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A three lncRNA set: AC009975.1, POTEH-AS1 and AL390243.1 as nodal efficacy biomarker of neoadjuvant therapy for HER-2 positive breast cancerDOI 10.21203/rs.3.rs-892533/v1
Select a neighboring publication to make it the new centre.